Our Philosophy

Science is the
only luxury
we trust.

At F.O.R.U. Laboratories, every formula begins with a question: what does the skin actually need, at the molecular level? Then we answer it.

01

Nano-delivery
technology.

Conventional skincare deposits actives on the skin's surface. At F.O.R.U., we begin where others stop. Our nano-encapsulation platform reduces active molecules to particles between 20–80 nanometres — smaller than the intercellular space of the stratum corneum.

The result: actives penetrate to the viable epidermis and dermis, where they can influence cellular behaviour, rather than simply resting on a barrier they cannot cross.

98% Absorption rate vs 20–30% conventional
50nm Average particle size
Deeper than standard delivery
Nano-encapsulation cross-section at 10,000× magnification.
Molecular mapping of Nano-Hyaluronic Acid complex.
02

Molecular
precision.

Every active in a F.O.R.U. formula is selected not for its marketing appeal but for its mechanism of action. We examine each ingredient at the receptor level — understanding exactly which biological pathway it influences, at what concentration, and with what interaction profile.

No fillers. No performance ingredients that exist to justify price points. Every molecule earns its place through mechanism.

Mechanism-first formulation We ask what the molecule does, not what it is called.
Concentration ethics Every active is present at its clinically validated threshold — never a trace amount for label decoration.
Interaction mapping All ingredients are assessed for synergy or antagonism before combination.
03

Clinical
results.

Our formulas are tested in double-blind, placebo-controlled trials at partner clinical dermatology centres. We do not publish results that have not been independently verified. We do not round numbers.

Below are the verified results from our current core collection at 12-week assessment.

Hydration improvement +67% vs baseline in 89% of participants.
Fine line reduction Average 31% reduction in periorbital lines at 12 weeks.
Pigmentation correction Visible improvement in 94% of participants with Grade II melasma.
Barrier function TEWL reduction of 44% versus control group.
Dermatology clinical trial centre, 12-week assessment protocol.
04

The standard
we hold ourselves to.

We source every raw material with the same rigour we apply to formulation. All suppliers hold ISO 22716 GMP certification. We maintain full chain of custody documentation from molecular synthesis to finished product. Our carbon footprint targets are published annually. Our packaging is 100% refillable by 2026.

ISO 22716 GMP
Clinical verification
Cruelty-free
Vegan formula
Refillable packaging
Carbon neutral 2025
Apply the Science

Your skin.
Our science.

Let V.E.R.A. map your biology and prescribe the formulas engineered precisely for it.